A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients With Locally Advanced or Metastatic Cancers

immuneACCESS ◽  
2021 ◽  
Author(s):  
A Diab ◽  
O Hamid ◽  
JA Thompson ◽  
W Ros ◽  
FALM Eskens ◽  
...  
2021 ◽  
pp. clincanres.0845.2021
Author(s):  
Adi Diab ◽  
Omid Hamid ◽  
John A Thompson ◽  
Willeke Ros ◽  
Ferry A.L.M. Eskens ◽  
...  

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3033-3033 ◽  
Author(s):  
A. L. Ho ◽  
J. C. Bendell ◽  
J. M. Cleary ◽  
G. K. Schwartz ◽  
H. A. Burris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document